Ablation Technology Market Share

Report ID: 2971
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Asia Pacific industry is estimated to dominate majority revenue share by 2037, due to various factors such as growing awareness, growing population, increasing income, eating habits, and changing lifestyles in the region. Furthermore, North America overtops the overall market in terms of market share due to the growing demand for minimally invasive procedures and increasing usage rates of ablation procedures. Along with this, North America also leads in terms of ongoing clinical trials, which is also expected to contribute to the region's market growth. As per the analysis of Centres for Disease Control and Prevention, U.S, in 2018, Atrial Fibrillation was mentioned on 175,326 death certificates and was the underlying cause of death in 25,845 of those deaths.

Browse key industry insights with market data tables & charts from the report:

Ablation Technology Market Size & Share, Growth Trends 2037

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ablation technology is assessed at USD 6.77 billion.

Ablation Technology Market size was valued at USD 6.27 billion in 2024 and is expected to reach USD 19.92 billion by 2037, registering around 9.3% CAGR during the forecast period i.e., between 2025-2037.

The major players in the market are Medtronic PLC, Biosense Webster Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Angiodynamics, Inc., Atricure, Inc., Conmed Corporation, Olympus Corporation and others.